Merrimack Pharmaceuticals, Inc.
MACK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,181 | -$1,544 | -$2,455 | -$3,028 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $160 | $71 | $397 | $1,722 |
| Change in WC | -$64 | $176 | $1,984 | -$1,180 |
| Other Non-Cash | -$437 | -$445 | -$144 | -$2,139 |
| Operating Cash Flow | -$1,522 | -$1,742 | -$218 | -$4,625 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,588 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $6,000 | $0 | $0 | $0 |
| Other Inv. Act. | $139 | $445 | $144 | $2,139 |
| Investing Cash Flow | -$12,449 | $445 | $144 | $2,139 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $521 | $6,533 | $239 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $521 | $6,533 | $239 | -$56 |
| Financing Cash Flow | $521 | $6,533 | $239 | -$56 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13,450 | $5,236 | $165 | -$2,542 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,439 | $14,203 | $14,038 | $16,580 |
| End Cash | $5,989 | $19,439 | $14,203 | $14,038 |
| Free Cash Flow | -$1,522 | -$1,742 | -$218 | -$4,625 |